RxDoctor Payments Data

Nejra Tabakovic, PA

Physician Assistant · Clearwater, FLNPI 1376281949

Payments from drug & device makers

$10,663in general payments, 2019–2025

Across 409 payments — averaging $26.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$1K
  • Novartis$1K
  • Merck$830
  • Incyte Corporation$713
  • AstraZeneca$705
  • Johnson & Johnson$560
  • plus $6K from 52 others

What the payments were for

  • Food & beverage$10,44798%
  • Education$2162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.32$1,066
Novartis49$1,028
Merck32$830
Incyte Corporation23$713
AstraZeneca(2 entities)27$705
Johnson & Johnson(2 entities)22$560
Gilead22$493
Regeneron Healthcare Solutions, Inc.12$327
Pfizer13$283
Rigel Pharmaceuticals, Inc.6$270
Sobi, Inc9$243
Pharmacosmos Therapeutics Inc.9$215
Seagen Inc.11$207
Takeda Pharmaceuticals U.S.A., Inc.7$203
Lilly USA, LLC8$202
Sanofi6$190
Adaptive Biotechnologies Corporation2$173
Array Biopharma Inc7$172
GSK7$160
CSL Behring8$157
Eisai Inc.7$157
Bayer6$145
Foundation Medicine, Inc.3$141
Genentech USA, Inc.3$135
AbbVie6$131
Astellas Pharma Global Development1$125
Taiho Oncology, Inc.7$124
Jazz Pharmaceuticals Inc.6$122
Ipsen Biopharmaceuticals, Inc1$100
E.r. Squibb & Sons, L.L.C.5$100
CTI Biopharma Corp.2$94
Beigene USA, Inc.4$92
AVEO Pharmaceuticals, Inc.4$77
EMD Serono, Inc.3$74
Tersera Therapeutics LLC3$71
Karyopharm Therapeutics Inc.3$62
Agios Pharmaceuticals, Inc.3$54
Pharmaessentia USA Corporation2$54
Stemline Therapeutics Inc.2$53
Sun Pharmaceutical Industries Inc.3$49
ADC Therapeutics America, Inc.2$47
Kyowa Kirin, Inc.2$46
Sumitomo Pharma America, Inc.2$46
Morphosys, US Inc.2$45
Puma Biotechnology, Inc.2$39
Genmab U.S., Inc.1$34
Beone Medicines USA, Inc.1$27
Alnylam Pharmaceuticals Inc.1$23
Progenics Pharmaceuticals, Inc.1$23
Geron Corporation1$22
Boehringer Ingelheim1$22
Mirati Therapeutics, Inc.1$21
Amgen1$21
Myriad Genetic Laboratories, Inc.1$19
Astellas Pharma US Inc1$19
Servier Pharmaceuticals LLC1$18
Verity Pharmaceuticals Inc.1$15
Novocure Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,663 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$19,353
Medicare patients
137
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$15,081
Tamoxifen Citrate12$545
Ondansetron OdtOndansetron16$231
Letrozole14$199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$283$15,08117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →